Related Experiment Videos
DNA repair inhibition and cancer therapy
1KuDOS Pharmaceuticals Ltd, 327 Cambridge Science Park, Milton Road, Cambridge, Cambs. CB4 4WG, UK. nmartin@kudospharma.co.uk
Abstract:
The DNA repair process in mammalian cells is a multi-pathway mechanism that protects cells from the plethora of DNA damaging agents that are known to attack nuclear DNA. Moreover, the majority of current anticancer therapies (e.g. ionising radiation and chemotoxic therapies) rely on this ability to create DNA lesions, leading to apoptosis/cell death. A cells natural ability to repair such DNA damage is a major cause of resistance to these existing antitumour agents. It seems logical, therefore, that by modulating these repair mechanisms, greater killing effect to anticancer agents would occur. Experimental data support this, either through knockout studies or by the use of pharmacological inhibitors which target some of the key regulatory proteins involved in the DNA repair process. Several of these key DNA repair proteins which are actively under investigation as novel sites for intervention in cancer biology are discussed.
Insights
Mammalian cells possess DNA repair mechanisms that protect against DNA damage. Modulating these natural repair processes could enhance the effectiveness of anticancer therapies by overcoming treatment resistance.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genetics
Background:
- Mammalian cells employ complex DNA repair pathways to counteract endogenous and exogenous DNA-damaging agents.
- Current anticancer therapies, including radiation and chemotherapy, induce DNA lesions to trigger cancer cell death.
- Inherent DNA repair capabilities in cancer cells contribute significantly to therapeutic resistance.
Purpose of the Study:
- To explore the potential of modulating DNA repair mechanisms to improve anticancer agent efficacy.
- To identify key DNA repair proteins as novel targets for cancer intervention.
Main Methods:
- Review of experimental data, including knockout studies.
- Investigation of pharmacological inhibitors targeting DNA repair proteins.
- Discussion of key regulatory proteins in DNA repair pathways.
Main Results:
- Experimental evidence supports the hypothesis that modulating DNA repair enhances anticancer agent-induced cell death.
- Targeting specific DNA repair proteins shows promise in overcoming treatment resistance.
Conclusions:
- Interfering with DNA repair pathways represents a viable strategy to potentiate existing cancer treatments.
- Several DNA repair proteins are emerging as critical targets for novel cancer therapies.